Pay in 4 interest-free payments of $5.25 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
A study on spinal cord injury in rats found that thymosin beta-4 treatment markedly improved behavioral assessments when administered within days of injury
EachNASAL contains BPC-157 10 mg
Tirzepatide, on the other hand, is a dual agonist, targeting both the GLP-1 and GIP receptors, offering enhanced glucose control and weight loss by combining the effects of both incretin hormones
TB-500 (43 residues, Thymosin Beta-4 fragment) regulates G-actin and cytoskeletal dynamics with broader systemic distribution
US$ 28.04
US$ 26.03
US$ 29.54
